Table 2 Comparison of baseline characteristics between two groups
|  | IMN-W (n = 9) | IMN-R (n = 10) | P-value |
|---|---|---|---|
Age | 56 (37–74) | 59 (36–84) | 0.702 |
Male, n (%) | 5 (56) | 6 (60) | 0.605 |
DM, n (%) | 6 (67) | 5 (50) | 0.395 |
Hypertension, n (%) | 7 (78) | 4 (40) | 0.115 |
Hemoglobin (mg/dl) | 12.8 (11.1–15.1) | 12.5 (10.0–18.0) | 0.447 |
Serum albumin (mg/dl) | 2.2 (1.6–3.6) | 2.3 (1.5–3.0) | 0.968 |
Triglyceride (mg/dl) | 242 (146–871) | 209 (123–611) | 0.447 |
eGFR (ml/min/1.73m2) | 89 (42–110) | 75 (48–109) | 0.549 |
24 h-proteinuria, baseline | 6462 (110–17,296) | 8084 (2148–13,044) | 0.356 |
Anti-PLA2R Ab | 0.6 (1–214) | 61.2 (1–566) | 0.258 |
Treatment regimen | Â | Â | Â |
ACEi or ARB | 7 (78) | 10 (100) | 0.211 |
Immunosuppressive drugs | 6 (67) | 5 (50) | 0.395 |
CsA + Steroid | 3 | 3 |  |
CTX + Steroid | 2 | 1 |  |
Tac + Steroid | 1 | 1 |  |